Cargando…
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients.
The possible use of liposomes (phospholipid vesicles) to direct cytotoxic drugs to tumours has led us to investigate the tissue localization of i.v. injected 99m-Tc-labelled liposomes in cancer patients. Twenty mg or 300 mg doses of liposomal lipid (7:2:1 molar ratio of phosphatidylcholine : cholest...
Autores principales: | Richardson, V. J., Ryman, B. E., Jewkes, R. F., Jeyasingh, K., Tattersall, M. N., Newlands, E. S., Kaye, S. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009957/ https://www.ncbi.nlm.nih.gov/pubmed/475960 |
Ejemplares similares
-
Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties
por: Alkandari, Anfal M., et al.
Publicado: (2022) -
Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours.
por: Rowell, N. P., et al.
Publicado: (1989) -
Labeling of Tannic Acid with Technetium-99m for Diagnosis of Stomach Ulcer
por: Ibrahim, I. T., et al.
Publicado: (2011) -
Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
por: De Silva, Leanne, et al.
Publicado: (2019) -
Technetium-99m Labeled Tropane Derivative: Uptake in a Pituitary Macroadenoma
por: Angamuthu, Meivel, et al.
Publicado: (2019)